Neurodevelopmental outcome at two years of age and predictive value of General Movement Assessment in infants exposed to alcohol and/or drugs during pregnancy: a prospective cohort study.
Alcohol exposure
Cognition
Drug exposure
Early infant behaviour
Language
Motor skills
Neurodevelopment
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
21 Sep 2024
21 Sep 2024
Historique:
received:
23
01
2024
accepted:
02
09
2024
medline:
21
9
2024
pubmed:
21
9
2024
entrez:
20
9
2024
Statut:
epublish
Résumé
Exposure to alcohol and/or other addictive drugs in pregnancy is a documented risk factor for neurological impairment. We aimed to assess neurodevelopmental outcome at two years of age in infants exposed to prenatal alcohol and/or other addictive drugs and to examine the predictive value of early motor assessment. This was a follow-up at two years of age in the prospective cohort study Children Exposed to Alcohol and/or Drugs in Intrauterine Life (CEADIL). The exposed group comprised 73 infants recruited from primary health care and included in a hospital follow-up programme at St. Olavs Hospital, Trondheim University Hospital, Norway. The control group comprised 93 healthy, unexposed infants recruited from the maternity ward at the same hospital. All children had been assessed by physiotherapists using the General Movement Assessment (GMA) at three months of age. Presence of fidgety movements, movement character and the Motor Optimality Score - Revised (MOS-R) were used. At two years of age, the children were assessed by trained examiners using the Bayley Scales of Infant and Toddler Development - Third Edition (BSID-III), Ages & Stages Questionnaires: Social-Emotional (ASQ:SE) and the Hollingshead Two-Factor Index of Social Position (SES). The cognitive, language and motor composite scores of BSID-III were considerably lower in the exposed group than in the control group. Mean differences adjusted for age and parental SES ranged from - 13.3 (95% confidence interval, CI: -18.6 to -8.0) to -17.7 (95% CI: -23.3 to -12.2). Suboptimal fidgety movements and monotonous movement character had high sensitivity (0.94 to 0.74), but low specificity (0.10 to 0.32), while sensitivity and specificity of the MOS-R was around 50 and 60%, respectively. Neurodevelopmental outcome at two years of age was poorer in a group of children exposed to alcohol and/or drugs in pregnancy compared with a control group of healthy, unexposed children. Sensitivity of suboptimal fidgety movements and monotonous movement character at three months of age for later neurodevelopmental outcome was high to acceptable, but the MOS-R had limited sensitivity.
Sections du résumé
BACKGROUND
BACKGROUND
Exposure to alcohol and/or other addictive drugs in pregnancy is a documented risk factor for neurological impairment. We aimed to assess neurodevelopmental outcome at two years of age in infants exposed to prenatal alcohol and/or other addictive drugs and to examine the predictive value of early motor assessment.
METHODS
METHODS
This was a follow-up at two years of age in the prospective cohort study Children Exposed to Alcohol and/or Drugs in Intrauterine Life (CEADIL). The exposed group comprised 73 infants recruited from primary health care and included in a hospital follow-up programme at St. Olavs Hospital, Trondheim University Hospital, Norway. The control group comprised 93 healthy, unexposed infants recruited from the maternity ward at the same hospital. All children had been assessed by physiotherapists using the General Movement Assessment (GMA) at three months of age. Presence of fidgety movements, movement character and the Motor Optimality Score - Revised (MOS-R) were used. At two years of age, the children were assessed by trained examiners using the Bayley Scales of Infant and Toddler Development - Third Edition (BSID-III), Ages & Stages Questionnaires: Social-Emotional (ASQ:SE) and the Hollingshead Two-Factor Index of Social Position (SES).
RESULTS
RESULTS
The cognitive, language and motor composite scores of BSID-III were considerably lower in the exposed group than in the control group. Mean differences adjusted for age and parental SES ranged from - 13.3 (95% confidence interval, CI: -18.6 to -8.0) to -17.7 (95% CI: -23.3 to -12.2). Suboptimal fidgety movements and monotonous movement character had high sensitivity (0.94 to 0.74), but low specificity (0.10 to 0.32), while sensitivity and specificity of the MOS-R was around 50 and 60%, respectively.
CONCLUSIONS
CONCLUSIONS
Neurodevelopmental outcome at two years of age was poorer in a group of children exposed to alcohol and/or drugs in pregnancy compared with a control group of healthy, unexposed children. Sensitivity of suboptimal fidgety movements and monotonous movement character at three months of age for later neurodevelopmental outcome was high to acceptable, but the MOS-R had limited sensitivity.
Identifiants
pubmed: 39304852
doi: 10.1186/s12887-024-05046-w
pii: 10.1186/s12887-024-05046-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
598Informations de copyright
© 2024. The Author(s).
Références
Hoyme HE, Kalberg WO, Elliott AJ, Blankenship J, Buckley D, Marais AS et al. Updated clinical guidelines for diagnosing fetal Alcohol Spectrum disorders. Pediatrics. 2016;138(2).
Lange S, Probst C, Gmel G, Rehm J, Burd L, Popova S. Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and Meta-analysis. JAMA Pediatr. 2017;171(10):948–56.
doi: 10.1001/jamapediatrics.2017.1919
pubmed: 28828483
pmcid: 5710622
Jacobson JL, Akkaya-Hocagil T, Ryan LM, Dodge NC, Richardson GA, Olson HC, et al. Effects of prenatal alcohol exposure on cognitive and behavioral development: findings from a hierarchical meta-analysis of data from six prospective longitudinal U.S. cohorts. Alcohol Clin Exp Res. 2021;45(10):2040–58.
doi: 10.1111/acer.14686
pubmed: 34342030
pmcid: 8602737
Forray A. Substance use during pregnancy. F1000Res. 2016;5.
Paul SE, Hatoum AS, Fine JD, Johnson EC, Hansen I, Karcher NR, et al. Associations between prenatal Cannabis exposure and childhood outcomes: results from the ABCD Study. JAMA Psychiatry. 2021;78(1):64–76.
doi: 10.1001/jamapsychiatry.2020.2902
pubmed: 32965490
Ryan SA, Ammerman SD, O’Connor ME, Substance CO. USE, Prevention, Section on B. Marijuana Use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes. Pediatrics. 2018;142(3).
Wang X, Zhang T, Ekheden I, Chang Z, Hellner C, Jan H, et al. Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: a systematic review. Neurosci Biobehav Rev. 2022;137:104647.
doi: 10.1016/j.neubiorev.2022.104647
pubmed: 35367514
Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA. 2001;285(12):1613–25.
doi: 10.1001/jama.285.12.1613
pubmed: 11268270
pmcid: 2504866
Arendt R, Angelopoulos J, Salvator A, Singer L. Motor development of cocaine-exposed children at age two years. Pediatrics. 1999;103(1):86–92.
doi: 10.1542/peds.103.1.86
pubmed: 9917444
Bandstra ES, Morrow CE, Mansoor E, Accornero VH. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis. 2010;29(2):245–58.
doi: 10.1080/10550881003684871
pubmed: 20407980
Richardson GA, Goldschmidt L, Larkby C, Day NL. Effects of prenatal cocaine exposure on adolescent development. Neurotoxicol Teratol. 2015;49:41–8.
doi: 10.1016/j.ntt.2015.03.002
pubmed: 25778776
pmcid: 4458454
Dodge NC, Jacobson JL, Jacobson SW. Effects of fetal substance exposure on offspring substance use. Pediatr Clin North Am. 2019;66(6):1149–61.
doi: 10.1016/j.pcl.2019.08.010
pubmed: 31679604
pmcid: 6986376
Eriksson M, Jonsson B, Steneroth G, Zetterstrom R. Amphetamine abuse during pregnancy: environmental factors and outcome after 14–15 years. Scand J Public Health. 2000;28(2):154–7.
doi: 10.1177/140349480002800212
pubmed: 10954143
Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W, et al. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol. 2011;33(1):176–84.
doi: 10.1016/j.ntt.2010.10.004
pubmed: 21256431
pmcid: 3033584
Garey JD, Lusskin SI, Scialli AR. Teratogen update: amphetamines. Birth Defects Res. 2020;112(15):1171–82.
doi: 10.1002/bdr2.1774
pubmed: 32755038
Topley J, Windsor D, Williams R. Behavioural, developmental and child protection outcomes following exposure to Class A drugs in pregnancy. Child Care Health Dev. 2008;34(1):71–6.
doi: 10.1111/j.1365-2214.2007.00768.x
pubmed: 18171447
Einspieler C, Prechtl HFR, Bos AF, Ferrari F, Cioni G. Prechtl’s method on the qualitative Assessment of General movements in Preterm, Term and Young infants. London: Mac Keith; 2004.
Piper MC, Darrah J. Motor Assessment of the developing infant. Philadelphia: Saunders; 1994.
Fjortoft T, Brandal M, Brubakk AM, Adde L, Ustad T, Vagen R, et al. Maternal alcohol and drug use during pregnancy affects the motor behaviour and general movements of infants aged 3-4months. Early Hum Dev. 2020;151:105171.
doi: 10.1016/j.earlhumdev.2020.105171
pubmed: 32977207
Novak I, Morgan C, Adde L, Blackman J, Boyd RN, Brunstrom-Hernandez J, et al. Early, Accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr. 2017;171(9):897–907.
doi: 10.1001/jamapediatrics.2017.1689
pubmed: 28715518
pmcid: 9641643
Prechtl HF, Einspieler C, Cioni G, Bos AF, Ferrari F, Sontheimer D. An early marker for neurological deficits after perinatal brain lesions. Lancet. 1997;349(9062):1361–3.
doi: 10.1016/S0140-6736(96)10182-3
pubmed: 9149699
Peyton C, Einspieler C. General movements: a behavioral biomarker of later motor and cognitive dysfunction in NICU graduates. Pediatr Ann. 2018;47(4):e159–64.
doi: 10.3928/19382359-20180325-01
pubmed: 29668025
Einspieler C, Bos AF, Libertus ME, Marschik PB. The General Movement Assessment Helps Us to identify Preterm infants at Risk for Cognitive Dysfunction. Front Psychol. 2016;7:406.
doi: 10.3389/fpsyg.2016.00406
pubmed: 27047429
pmcid: 4801883
Palchik AB, Einspieler C, Evstafeyeva IV, Talisa VB, Marschik PB. Intra-uterine exposure to maternal opiate abuse and HIV: the impact on the developing nervous system. Early Hum Dev. 2013;89(4):229–35.
doi: 10.1016/j.earlhumdev.2013.02.004
pubmed: 23490656
Parisi P, Francia A, Vanacore N, Fiore S, Giallonardo AT, Manfredi M. Psychomotor development and general movements in offspring of women with epilepsy and anticonvulsant therapy. Early Hum Dev. 2003;74(2):97–108.
doi: 10.1016/S0378-3782(03)00083-5
pubmed: 14580750
Hollingshead AB. Two-factor index of social position. New Haven: Harvard University; 1957.
Einspieler C, Bos AF, Krieber-Tomantschger M, Alvarado E, Barbosa VM, Bertoncelli N et al. Cerebral palsy: early markers of clinical phenotype and functional outcome. J Clin Med. 2019;8(10).
Caesar RA, Boyd RN, Cioni G, Ware RS, Doherty J, Jackson MP, et al. Early detection of developmental delay in infants born very preterm or with very low birthweight. Dev Med Child Neurol. 2023;65(3):346–57.
doi: 10.1111/dmcn.15381
pubmed: 37017185
Bayley N. Bayley Scales of Infant and Toddler Development - Third Edition: Technical Manual. San Antonio, TX: Hardcourt Assessment; 2006.
Squires JBD, Twombly E. The ASQ:SE user’s guide. Baltimore: Paul H. Brookes Publishing Co; 2002.
Altman DG. Practical statistics for medical research. London: Chapman and Hall; 1999.
Bradley RH, Corwyn RF. Socioeconomic status and child development. Annu Rev Psychol. 2002;53:371–99.
doi: 10.1146/annurev.psych.53.100901.135233
pubmed: 11752490
Vasquez-Echeverria A, Alvarez-Nunez L, Gonzalez M, Loose T, Rudnitzky F. Role of parenting practices, mother’s personality and depressive symptoms in early child development. Infant Behav Dev. 2022;67:101701.
doi: 10.1016/j.infbeh.2022.101701
pubmed: 35192935